Cargando…
Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection
Fecal microbiota transplantation (FMT) has become a common rescue therapy for recurrent Clostridium difficile infection, and encapsulated delivery (cFMT) of healthy donor microbiota shows similar clinical efficacy as more traditional routes of administration. In this study, we characterized long-ter...
Autores principales: | Staley, Christopher, Kaiser, Thomas, Vaughn, Byron P., Graiziger, Carolyn, Hamilton, Matthew J., Kabage, Amanda J., Khoruts, Alexander, Sadowsky, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650559/ https://www.ncbi.nlm.nih.gov/pubmed/31337728 http://dx.doi.org/10.1128/mBio.01586-19 |
Ejemplares similares
-
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018) -
A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis
por: Vaughn, Byron P, et al.
Publicado: (2019) -
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016) -
Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration
por: Staley, Christopher, et al.
Publicado: (2021) -
Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
por: Shankar, Vijay, et al.
Publicado: (2014)